A case of ovarian carcinosarcoma with a germline pathogenic variant of BRCA2 involving a perforated appendix with an abscess

J Obstet Gynaecol Res. 2023 Oct;49(10):2553-2557. doi: 10.1111/jog.15736. Epub 2023 Jul 18.

Abstract

We report a case of rare and aggressive ovarian carcinosarcoma with a germline pathogenic BRCA2 variant. A patient with a history of breast cancer who developed an inflammatory ovarian tumor with peritonitis carcinomatosis involving the appendix suffered from cachexia. Following three cycles of weekly paclitaxel and carboplatin chemotherapy, emergency surgery was required owing to sepsis. Bilateral salpingo-oophorectomy, total hysterectomy, appendectomy, and small intestine adhesiolysis were performed. Histologically, the tumor comprised an admixture of carcinomatous and sarcomatous components, with involvement of the appendix, which had caused perforation and abscess formation. The final diagnosis was ovarian carcinosarcoma with a germline pathogenic BRCA2 variant, c.658_659del (p.Val220fs). The patient responded completely to adjuvant chemotherapy. A combination of chemotherapy and surgery might be beneficial to patients with ovarian carcinosarcoma and germline pathogenic BRCA2 variants with a poor general condition. This is the first report of ovarian carcinosarcoma with a germline pathogenic BRCA2 variant that responded favorably to chemotherapy.

Keywords: BRCA2; chemotherapy; germline pathogenic variant; ovarian carcinosarcoma; perforated appendix.

Publication types

  • Case Reports

MeSH terms

  • Abscess
  • Appendix* / pathology
  • BRCA2 Protein
  • Carcinosarcoma* / complications
  • Carcinosarcoma* / drug therapy
  • Carcinosarcoma* / genetics
  • Female
  • Germ Cells / pathology
  • Humans
  • Ovarian Neoplasms* / complications
  • Ovarian Neoplasms* / drug therapy
  • Ovarian Neoplasms* / genetics

Substances

  • BRCA2 protein, human
  • BRCA2 Protein